Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 20 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

20 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Dec. 2, 2021 CNTA P 796 $12.82 $10,205 93,526 Indirect +0.86% Acquired
Dec. 2, 2021 CNTA P 33,530 $12.82 $429,855 3,936,970 Indirect +0.86% Acquired
Dec. 1, 2021 CNTA P 1,399 $12.62 $17,655 92,730 Indirect +1.53% Acquired
Dec. 1, 2021 CNTA P 58,905 $12.62 $743,381 3,903,440 Indirect +1.53% Acquired
Nov. 30, 2021 CNTA P 855 $11.62 $9,935 91,331 Indirect +0.95% Acquired
Nov. 30, 2021 CNTA P 35,992 $11.62 $418,227 3,844,535 Indirect +0.95% Acquired
Nov. 29, 2021 CNTA P 1,315 $11.70 $15,386 90,476 Indirect +1.47% Acquired
Nov. 29, 2021 CNTA P 55,391 $11.70 $648,075 3,808,543 Indirect +1.48% Acquired
Nov. 26, 2021 CNTA P 274 $11.34 $3,107 89,161 Indirect +0.31% Acquired
Nov. 26, 2021 CNTA P 11,543 $11.34 $130,898 3,753,152 Indirect +0.31% Acquired
June 2, 2021 CNTA P 13,923 $20.00 $278,460 88,887 Indirect +18.57% Acquired
June 2, 2021 CNTA P 586,077 $20.00 $11,721,540 3,741,609 Indirect +18.57% Acquired
Aug. 10, 2016 NERV S 1,000,000 $10.00 $10,000,000 4,488,272 Indirect -18.22% Disposed -95.9% (price as of 2026-10-02)
March 18, 2015 NERV P 202,634 $0.12 $24,316 202,634 Indirect · Acquired 241.7% (price as of 2026-10-02)
March 18, 2015 NERV P 202,634 $4.81 $974,670 5,488,272 Indirect +3.83% Acquired -91.5% (price as of 2026-10-02)
July 7, 2014 NERV P 333,333 $6.00 $1,999,998 5,285,638 Indirect +6.73% Acquired -93.2% (price as of 2026-10-02)
July 7, 2014 NERV P 1,287,500 $6.00 $7,725,000 4,952,305 Indirect +35.13% Acquired -93.2% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 2, 2021 CNTA Series A Preferred Shares Ordinary Shares [F1] (44,828) · · 44,828 Disposed
June 2, 2021 CNTA Series A Preferred Shares Ordinary Shares [F1] (1,886,990) · · 1,886,990 Disposed
Jan. 29, 2021 CNTA Series A Preferred Shares Ordinary Shares [F1] · · 44,828 Acquired
Jan. 29, 2021 CNTA Series A Preferred Shares Ordinary Shares [F1] · · 1,886,990 Acquired
Dec. 12, 2016 NERV Warrant Shares Common Shares $5.77 March 18, 2017 202,634 Disposed
March 18, 2015 NERV Warrant Shares Common Shares (202,634) $5.77 March 18, 2017 202,634 Acquired
July 7, 2014 NERV Convertible Promissory Note Convertible Promissory Note (61,922) · · 61,922 Disposed
July 7, 2014 NERV Convertible Promissory Note Convertible Promissory Note (114,077) · · 114,077 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 11 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 27, 2021 CNTA Ordinary Shares [F1,F2] 4,398,519 Indirect
May 27, 2021 CNTA Ordinary Shares [F1,F2] 55,677 Indirect
May 27, 2021 CNTA Ordinary Shares [F1,F2] 1,268,542 Indirect
May 27, 2021 CNTA Ordinary Shares [F1,F2] 30,136 Indirect
May 27, 2021 CNTA Ordinary Shares [F1,F2] 9,403,092 Indirect
May 27, 2021 CNTA Ordinary Shares [F1,F2] 236,108 Indirect
May 27, 2021 CNTA Series A Preferred Shares→ Ordinary Shares [F2] (1,886,990) 1,886,990 Indirect
May 27, 2021 CNTA Series A Preferred Shares→ Ordinary Shares [F2] (44,828) 44,828 Indirect
June 30, 2014 NERV Common Stock 3,436,898 Indirect
June 30, 2014 NERV Convertible Promissory Notes→ Common Stock (113,891) 113,891 Indirect
June 30, 2014 NERV Convertible Promissory Notes→ Common Stock (61,913) 61,913 Indirect